* Sensus Healthcare Inc SRTS.OQ SRTS.O is expected to show
a rise in quarterly revenue when it reports results on May 6.
* The Boca Raton, Florida-based company is expected to report
a 120.0% increase in revenue to $3.694 million from $1.68
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sensus Healthcare Inc
is for a loss of 10 cents per share. For the same quarter last
year, the company reported a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Sensus
Healthcare Inc is $6.5, about 44% above its last closing price
of $3.64.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 -0.10 -0.11 0.02 Beat 117.9
Sep. 30 2020 -0.14 -0.13 -0.14 Missed -3.7
Jun. 30 2020 -0.18 -0.18 -0.16 Beat 11.1
Mar. 31 2020 -0.08 -0.07 -0.22 Missed -222
Dec. 0.02 0.03 0.06 Beat 111.8
31 2019
Sep. 30 2019 -0.04 -0.03 -0.04 Missed -20
Jun. 30 2019 -0.07 -0.05 0.01 Beat 119.4
Mar. 31 2019 -0.03 -0.03 -0.13 Missed -279.1
This summary was machine generated May 5 at 02:00 GMT. All
figures in US dollars unless otherwise stated